Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.
Iwamoto N, Kawakami A, Fujikawa K, Aramaki T, Kawashiri SY, Tamai M, Arima K, Ichinose K, Kamachi M, Yamasaki S, Nakamura H, Nakashima M, Mizokami A, Goto A, Fukuda T, Matsuoka N, Ueki Y, Tsukada T, Migita K, Shoumura F, Kawabe Y, Shibatomi K, Mine M, Ida H, Origuchi T, Aoyagi K, Eguchi K. Iwamoto N, et al. Among authors: mine m. Mod Rheumatol. 2009;19(5):488-92. doi: 10.1007/s10165-009-0187-8. Epub 2009 Jul 4. Mod Rheumatol. 2009. PMID: 19578932
Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
Kawashiri SY, Nishino A, Suzuki T, Nakashima Y, Horai Y, Ueki Y, Aramaki T, Fujikawa K, Nakashima M, Okada A, Migita K, Mizokami A, Matsuoka N, Mine M, Sakito S, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Aoyagi K, Eguchi K, Kawakami A. Kawashiri SY, et al. Among authors: mine m. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):808-812. Epub 2016 Jun 22. Clin Exp Rheumatol. 2016. PMID: 27384149
Clinical outcome and survival of secondary (AA) amyloidosis.
Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Tanaka F, et al. Among authors: mine m. Clin Exp Rheumatol. 2003 May-Jun;21(3):343-6. Clin Exp Rheumatol. 2003. PMID: 12846054
Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor.
Origuchi T, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, Tamai M, Arima K, Nakamura H, Yamasaki S, Ida H, Kawakami A, Ueki Y, Matsuoka N, Nakashima M, Mizokami A, Kawabe Y, Mine M, Fukuda T, Eguchi K. Origuchi T, et al. Among authors: mine m. Mod Rheumatol. 2011 Jun;21(3):244-50. doi: 10.1007/s10165-010-0384-5. Epub 2010 Dec 29. Mod Rheumatol. 2011. PMID: 21188454
Interleukin-1 production and action in thyroid tissue.
Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K, et al. Kawabe Y, et al. Among authors: mine m. J Clin Endocrinol Metab. 1989 Jun;68(6):1174-83. doi: 10.1210/jcem-68-6-1174. J Clin Endocrinol Metab. 1989. PMID: 2656735
269 results